| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Sep―21 |
Computer-aided drug discovery of potential semisynthetic inhibitors for SARS-CoV-2 main protease: A multi-phase computational approach |
Ahmed M Metwaly, Hazem Elkady, Eslam B Elkaeed, Abdelrahman M Saleh, Aisha A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa |
| 2 |
[GO] |
2025―Mar―27 |
Identification of lead small molecules for the design and development of potent severe acute respiratory syndrome coronavirus 2 main protease inhibitors |
Elvis Awuni |
| 3 |
[GO] |
2024―Nov―16 |
Discovery of potential FDA-approved SARS-CoV-2 Papain-like protease inhibitors: A multi-phase in silico approach |
Ahmed M Metwaly, Eslam B Elkaeed, Mohamed M Khalifa, Aisha A Alsfouk, Fatma G Amin, Ibrahim M Ibrahim, Ibrahim H Eissa |
| 4 |
[GO] |
2024―Jan―08 |
Computer-aided drug discovery of natural antiviral metabolites as potential SARS-CoV-2 helicase inhibitors |
Eslam B Elkaeed, Ibrahim H Eissa, Abdulrahman M Saleh, Bshra A Alsfouk, Ahmed M Metwaly |
| 5 |
[GO] |
2020―Jun―19 |
Strong inhibition of M-Protease activity of Coronavirus by using PX-12 inhibitor based on ab initio ONIOM calculations |
Hadieh Monajemi, Sharifuddin M Zain |
